Back
Novartis AG Vs. Monte Rosa Therapeutics Industry Stock Comparison
Sell
37
NVS
Novartis AG
Last Price:
$105.42
Seasonality Move:
1.66%
Sell
46
GLUE
Monte Rosa Therapeutics
Last Price:
$6.79
Seasonality Move:
-16.23%
Sell
37
Novartis AG (NVS)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVS] share price is $105.43. The Score for NVS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
NVS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
-
The current Monte Rosa Therapeutics [GLUE] share price is $6.78. The Score for GLUE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $105.43The current trend is moderately bullish and NVS is experiencing selling pressure, which indicates risk of future bearish movement.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $6.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing slight selling pressure.
NVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.85 | Buy |
Relative Strength Index (14 RSI): | 54.75 | Buy |
Chaikin Money Flow: | -1188510 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.37 - 106.75) | Buy |
Bollinger Bands (100): | (99.36 - 112.4) | Sell |
GLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 54.83 | Buy |
Chaikin Money Flow: | -53912 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.66 - 6.62) | Buy |
Bollinger Bands (100): | (5.4 - 8.6) | Sell |
NVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.22 | Sell |
20-day SMA: | 104.09 | Buy |
50-day SMA: | 101.06 | Buy |
200-day SMA: | 107.28 | Sell |
8-day EMA: | 106.45 | Sell |
20-day EMA: | 104.66 | Buy |
50-day EMA: | 103.44 | Buy |
200-day EMA: | 105.15 | Buy |
GLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.6 | Buy |
20-day SMA: | 6.23 | Buy |
50-day SMA: | 6.93 | Sell |
200-day SMA: | 5.88 | Buy |
8-day EMA: | 6.55 | Buy |
20-day EMA: | 6.45 | Buy |
50-day EMA: | 6.71 | Buy |
200-day EMA: | 6.37 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.99 per share, and an increase next year of $0.16 per share.
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.
Novartis AG Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monte Rosa Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |